Early psoriatic arthritis: when is the right time to start advanced therapy?

• Published in: Therapeutic Advances in Musculoskeletal Disease
• Main Authors: Or Hen, Stephanie R. Harrison, Gabriele De Marco, Helena Marzo-Ortega
• Format: Article
• Language: English
• Published: SAGE Publishing 2024-07-01
• Online Access: https://doi.org/10.1177/1759720X241266727

Despite significant advances in the treatment of psoriatic arthritis (PsA) in the last two decades, remission remains elusive and there is no cure. Evidence from rheumatoid arthritis (RA) confirming enhanced response and outcome from earlier treatment intervention suggests the plausibility of the window of opportunity in the pathogenesis of RA. Yet, data are lacking in PsA. Although treatment response may be enhanced in shorter disease duration, it is unknown how this early intervention may impact long-term outcomes. Furthermore, it remains to be demonstrated whether there is a best treatment strategy and time of intervention. Crucially, the main hurdle when aiming for early treatment intervention is the ability to achieve a timely diagnosis that highlights the need to focus research efforts on characterizing the very early disease stages including the transition to PsA in the at-risk psoriasis population.